Description
RAD-150 (TLB-150) Powder — 2 Grams
RAD-150, also designated TLB-150 or RAD-140 benzoate, is a synthetic benzoate ester of the non-steroidal selective androgen receptor modulator RAD-140 (testolone). It is catalogued as an androgen receptor modulator for research into esterified SARM analogs. This listing is a research-grade reference compound supplied in powder form for in vitro and laboratory investigation. Identity and purity are third-party verified and documented by a downloadable Certificate of Analysis.
- 99.8% purity (HPLC)
- Third-party verified
- 2,050 mg net
- Public COA
- UV-resistant foil pouch
Specifications & Documentation
- Compound
- RAD-150 (TLB-150 / RAD-140 benzoate)
- IUPAC Name
- 4-[[(1R,2S)-2-(benzoyloxy)-1-[5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl]propyl]amino]-2-chloro-3-methylbenzonitrile
- CAS Number
- 1208070-53-4
- Molecular Formula
- C₂₇H₂₀ClN₅O₃
- Molar Mass
- 497.93 g/mol
- Compound Class
- Esterified SARM derivative · Benzoate ester of RAD-140
- Parent Compound
- RAD-140 (testolone), CAS 1182367-47-0
- WADA Classification
- Prohibited — Class S1.2 (Other Anabolic Agents), which covers SARMs
- Form
- Crystalline powder
- Net Quantity
- 2,050 mg per pouch
Third-Party Verification
Identity and purity are independently confirmed by MZ Biolabs (Tucson, AZ), a US DEA Schedule III licensed analytical facility (License RP0584676), using HPLC purity analysis and mass-spectrometry identity confirmation under Good Laboratory Practice (GLP) standards to support research reproducibility.
- Latest COA Date
- 07.11.23
- Reported Purity
- 99.8%
- Methods
- HPLC purity; MS identity confirmation
- Verifying Lab
- MZ Biolabs, Tucson, AZ (DEA Schedule III, RP0584676)
Current certificate of analysis for RAD-150 (TLB-150), issued by MZ Biolabs. Tap to view full size.
Open or download the current RAD-150 COA · View the full COA archive →
Storage & Handling
Store in a cool, dry place away from direct sunlight to maximize shelf life. Supplied in a UV-resistant foil pouch to minimize photodegradation.
- Packaging
- UV-resistant sealed foil pouch
- Storage
- Cool, dry, dark; away from direct sunlight
- Handling
- Standard laboratory PPE and analytical-grade equipment
- Intended Use
- Laboratory and in vitro research only
Quality & Analytical Transparency
Independent analysis has repeatedly found that materials sold online as SARMs are frequently mislabeled or adulterated. A 2017 JAMA investigation that chemically analyzed products marketed as SARMs found that only a minority accurately matched their labeled contents, and a substantial share contained unapproved or entirely different substances.[4] Third-party testing is the control that distinguishes a documented reference compound from an unverified one.
Research Context
RAD-150 is structurally derived from RAD-140, a non-steroidal SARM developed by Radius Health whose preclinical characterization was published in 2011.[1] RAD-150 adds a benzoate ester at the hydroxyl group of the RAD-140 backbone, a modification of the kind commonly used to alter lipophilicity and metabolic stability. Unlike its parent compound, RAD-150 has essentially no dedicated peer-reviewed literature: its pharmacology, metabolism, and toxicology have not been characterized in published studies, and properties often attributed to it are extrapolated from RAD-140. RAD-140 itself has been associated with liver enzyme elevations in a Phase I trial and with case reports of drug-induced liver injury.[2][3] RAD-150 has never been evaluated in humans.
This material is supplied strictly as a reference compound to support such laboratory investigation. It is not a therapeutic product, dietary supplement, or sports supplement, and no clinical or performance outcomes are claimed or implied for any individual.
Compliance & Legal Status
RAD-150 (TLB-150) is an unapproved research compound that has not been approved by the U.S. Food and Drug Administration for human use. It is not a dietary supplement, and marketing it for human ingestion is unlawful. It is supplied exclusively for laboratory research purposes.
Scientific References
- Miller CP, Shomali M, Lyttle CR, et al. Design, synthesis, and preclinical characterization of the selective androgen receptor modulator (SARM) RAD140. ACS Med Chem Lett. 2011;2(2):124–129.
- LoRusso P, Hamilton E, Ma C, et al. A first-in-human phase 1 study of a novel selective androgen receptor modulator (SARM), RAD140, in ER+/HER2– metastatic breast cancer. Clin Breast Cancer. 2022;22(1):67–77.
- Flores JE, Chitturi S, Walker S. Drug-induced liver injury by selective androgenic receptor modulators. Hepatol Commun. 2020;4(3):450–452.
- Van Wagoner RM, Eichner A, Bhasin S, Deuster PA, Eichner D. Chemical Composition and Labeling of Substances Marketed as Selective Androgen Receptor Modulators and Sold via the Internet. JAMA. 2017;318(20):2004–2010.
- World Anti-Doping Agency. The Prohibited List, Section S1.2: Other Anabolic Agents. WADA.org.
Research Disclaimer
For laboratory research use only. This preparation is not approved by the FDA for human use. RAD-150 / TLB-150 is not a dietary or sports supplement and is not intended for human or animal consumption.
All products on this website are intended exclusively for research and development purposes. The statements herein have not been evaluated by the U.S. Food and Drug Administration. Neither the statements nor the products are intended to diagnose, treat, cure, or prevent any disease. Sports Technology Labs are chemical suppliers, not medical practitioners; our expertise is sourcing and quality control.





